CN104072397A - Synthesis method for aziridine derivative - Google Patents
Synthesis method for aziridine derivative Download PDFInfo
- Publication number
- CN104072397A CN104072397A CN201410319075.6A CN201410319075A CN104072397A CN 104072397 A CN104072397 A CN 104072397A CN 201410319075 A CN201410319075 A CN 201410319075A CN 104072397 A CN104072397 A CN 104072397A
- Authority
- CN
- China
- Prior art keywords
- aziridine derivative
- add
- synthetic method
- room temperature
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/02—Preparation by ring-closure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
Abstract
The invention discloses a synthesis method for an aziridine derivative. The synthesis method comprises the steps of adding phenyl isothiocyanate and an organic solvent into a reactor with a reflux condensing tube under the protection of N2, adding 2-bromine allyl amine, stirring at room temperature till the raw materials are dissolved completely, then adding cuprous iodide and alkali metal salt, stirring and heating up to 60-120DEG C, tracking the reaction process by thin layer chromatography till an intermediate thiourea disappears completely, after reacting, cooling the mixture to room temperature, adding a saturated ammonium chloride solution while stirring, extracting the mixture for many times by ethyl acetate, washing the organic layer by saturated salt water, then drying by anhydrous sodium sulfate, after rotary evaporation and concentration, and carrying out separation on columns by silica gel, so as to obtain the target product. The synthesis method for the aziridine derivative has the characteristics of easy availability of raw materials, simple operation, mild reaction conditions and the like, and is applicable to large-scale production.
Description
Technical field
The invention belongs to fine chemical technology field, relate to a kind of synthetic method of aziridine derivative.
Background technology
Aziridine, because its unique structure is a kind of important industrial chemicals and organic intermediate, is also the front body structure of a lot of synthetic drugss.1901, Germanization scholar Liv Ullmann was found the linked reaction under copper catalysis, and the Ullmann linked reaction of after this copper catalysis is the problem that organic chemists study always.In recent years, by synthetic some heterogeneous ring compound of copper catalyzed coupling reaction, become the focus of research, but be not yet seen in report by the method for synthetic aziridines compound under copper catalysis.
Summary of the invention
In view of this, the object of the present invention is to provide a kind of novel synthesis of aziridine derivative.
For achieving the above object, the invention provides following technical scheme:
A synthetic method for aziridine derivative, comprises the steps:
At N
2under protection, to being furnished with in the reaction unit of reflux condensing tube, add PITC and organic solvent, add 2-bromine allylamine, under room temperature, stir until raw material completely dissolve, add again cuprous iodide, an alkali metal salt, stir and be warming up to 60 ~ 120 ℃, with tlc, follow the tracks of reaction process until the completely dissolve of intermediate thiocarbamide, reaction finishes, mixture is cooled to room temperature, under stirring, add saturated ammonium chloride solution, mixture is extracted with ethyl acetate repeatedly, organic layer saturated common salt water washing, again through anhydrous sodium sulfate drying, after rotary evaporation is concentrated, with silica gel, carry out post separation, obtain target product.
In technique scheme, described organic solvent is any one in DMF, DMSO, THF.
In technique scheme, the consumption of described cuprous iodide catalyst is reaction substrate amount of substance 5 ~ 20%.
In technique scheme, described an alkali metal salt is salt of wormwood or cesium carbonate, and its consumption is reaction substrate 100 ~ 200%.
Preferably, add after cuprous iodide, an alkali metal salt, stir and be warming up to 100 ℃.
The features such as the synthetic method of aziridine derivative of the present invention has raw material and is easy to get, simple to operate, and reaction conditions is comparatively gentle, and applicable large-scale production.
Embodiment
Below the technical scheme in the embodiment of the present invention is described in detail, obviously, described embodiment is only the present invention's part embodiment, rather than whole embodiment.Embodiment based in the present invention, the every other embodiment that those of ordinary skills obtain under the prerequisite of not making creative work, belongs to the scope of protection of the invention.
Embodiment 1
At N
2under protection, to being furnished with in the reaction unit of reflux condensing tube, add 1mol PITC and 5L organic solvent DMSO, add 1mol 2-bromine allylamine, under room temperature, stir until raw material completely dissolve, add again 0.05mol cuprous iodide, 1mol an alkali metal salt, stir and be warming up to 60 ℃, with tlc, follow the tracks of reaction process until the completely dissolve of intermediate thiocarbamide, reaction finishes, mixture is cooled to room temperature, under stirring, add saturated ammonium chloride solution, mixture is extracted with ethyl acetate repeatedly, organic layer saturated common salt water washing, again through anhydrous sodium sulfate drying, after rotary evaporation is concentrated, with silica gel, carry out post separation, obtain target product.
Embodiment 2
At N
2under protection, to being furnished with in the reaction unit of reflux condensing tube, add 1mol PITC and 5L organic solvent DMF, add 1mol 2-bromine allylamine, under room temperature, stir until raw material completely dissolve, add again 0.1mol cuprous iodide, 1.5mol an alkali metal salt, stir and be warming up to 100 ℃, with tlc, follow the tracks of reaction process until the completely dissolve of intermediate thiocarbamide, reaction finishes, mixture is cooled to room temperature, under stirring, add saturated ammonium chloride solution, mixture is extracted with ethyl acetate repeatedly, organic layer saturated common salt water washing, again through anhydrous sodium sulfate drying, after rotary evaporation is concentrated, with silica gel, carry out post separation, obtain target product.
Embodiment 3
At N
2under protection, to being furnished with in the reaction unit of reflux condensing tube, add 1mol PITC and 5L organic solvent THF, add 1mol 2-bromine allylamine, under room temperature, stir until raw material completely dissolve, add again 0.2mol cuprous iodide, 2mol an alkali metal salt, stir and be warming up to 120 ℃, with tlc, follow the tracks of reaction process until the completely dissolve of intermediate thiocarbamide, reaction finishes, mixture is cooled to room temperature, under stirring, add saturated ammonium chloride solution, mixture is extracted with ethyl acetate repeatedly, organic layer saturated common salt water washing, again through anhydrous sodium sulfate drying, after rotary evaporation is concentrated, with silica gel, carry out post separation, obtain target product.
In those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and in the situation that not deviating from spirit of the present invention or essential characteristic, can realize the present invention with other specific form.Therefore, no matter from which point, all should regard embodiment as exemplary, and be nonrestrictive, scope of the present invention is limited by claims rather than above-mentioned explanation, is therefore intended to include in the present invention dropping on the implication that is equal to important document of claim and all changes in scope.
In addition, be to be understood that, although this specification sheets is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of specification sheets is only for clarity sake, those skilled in the art should make specification sheets as a whole, and the technical scheme in each embodiment also can, through appropriately combined, form other embodiments that it will be appreciated by those skilled in the art that.
Claims (5)
1. a synthetic method for aziridine derivative, is characterized in that, comprises the steps: at N
2under protection, to being furnished with in the reaction unit of reflux condensing tube, add PITC and organic solvent, add 2-bromine allylamine, under room temperature, stir until raw material completely dissolve, add again cuprous iodide, an alkali metal salt, stir and be warming up to 60 ~ 120 ℃, with tlc, follow the tracks of reaction process until the completely dissolve of intermediate thiocarbamide, reaction finishes, mixture is cooled to room temperature, under stirring, add saturated ammonium chloride solution, mixture is extracted with ethyl acetate repeatedly, organic layer saturated common salt water washing, again through anhydrous sodium sulfate drying, after rotary evaporation is concentrated, with silica gel, carry out post separation, obtain target product.
2. the synthetic method of aziridine derivative according to claim 1, is characterized in that: described organic solvent is any one in DMF, DMSO, THF.
3. the synthetic method of aziridine derivative according to claim 1, is characterized in that: the consumption of described cuprous iodide catalyst is reaction substrate amount of substance 5 ~ 20%.
4. the synthetic method of aziridine derivative according to claim 1, is characterized in that: described an alkali metal salt is salt of wormwood or cesium carbonate, and its consumption is reaction substrate 100 ~ 200%.
5. the synthetic method of aziridine derivative according to claim 1, is characterized in that: add after cuprous iodide, an alkali metal salt, stir and be warming up to 100 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410319075.6A CN104072397A (en) | 2014-07-07 | 2014-07-07 | Synthesis method for aziridine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410319075.6A CN104072397A (en) | 2014-07-07 | 2014-07-07 | Synthesis method for aziridine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104072397A true CN104072397A (en) | 2014-10-01 |
Family
ID=51594047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410319075.6A Pending CN104072397A (en) | 2014-07-07 | 2014-07-07 | Synthesis method for aziridine derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104072397A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115141421A (en) * | 2022-06-13 | 2022-10-04 | 刘建宏 | Antibacterial regenerated plastic and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988007038A1 (en) * | 1987-03-12 | 1988-09-22 | Nippon Shokubai Kagaku Kogyo Co., Ltd. | Process for producing aziridines |
CN1163265A (en) * | 1996-01-04 | 1997-10-29 | 巴斯福股份公司 | Process for preparing aziridines compound |
CN101679234A (en) * | 2007-06-20 | 2010-03-24 | 巴斯夫欧洲公司 | Method for synthesizing an n-unsubstituted or n-substituted aziridine |
CN102378577A (en) * | 2009-04-01 | 2012-03-14 | 朗盛德国有限责任公司 | Stabilization of compounds comprising iodine |
CN102627594A (en) * | 2012-03-20 | 2012-08-08 | 上海华谊(集团)公司 | Preparation method of waterless aziridine compound |
-
2014
- 2014-07-07 CN CN201410319075.6A patent/CN104072397A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988007038A1 (en) * | 1987-03-12 | 1988-09-22 | Nippon Shokubai Kagaku Kogyo Co., Ltd. | Process for producing aziridines |
CN1163265A (en) * | 1996-01-04 | 1997-10-29 | 巴斯福股份公司 | Process for preparing aziridines compound |
CN101679234A (en) * | 2007-06-20 | 2010-03-24 | 巴斯夫欧洲公司 | Method for synthesizing an n-unsubstituted or n-substituted aziridine |
CN102378577A (en) * | 2009-04-01 | 2012-03-14 | 朗盛德国有限责任公司 | Stabilization of compounds comprising iodine |
CN102627594A (en) * | 2012-03-20 | 2012-08-08 | 上海华谊(集团)公司 | Preparation method of waterless aziridine compound |
Non-Patent Citations (4)
Title |
---|
BJÖRN M. NILSSON等: "Urea and 2-Imidazolidone Derivatives of the Muscarinic Agents Oxotremorine and N-Methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
JASON J. SHIERS等: "Rare example of nucleophilic substitution at vinylic carbon with inversion: mechanism of methyleneaziridine formation by sodium amide induced ring closure revisited", 《J.AM.CHEM.SOC.》 * |
PAUL L. FISHBEIN等: "Synehtsis and antineoplastic activity of 1a-formyl and 1a-thioformal derivatives of mitomycin C and 2-methylaziridine", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
陈国广等: "对称和非对称取代硫脲的合成", 《精细化工》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115141421A (en) * | 2022-06-13 | 2022-10-04 | 刘建宏 | Antibacterial regenerated plastic and preparation method thereof |
CN115141421B (en) * | 2022-06-13 | 2023-12-08 | 汕头市骅隆玩具有限公司 | Antibacterial regenerated plastic and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104262344B (en) | The preparation method of Chinese mugwort Dana Delany | |
CN102584795B (en) | Preparing method of crizotinib | |
CN107216313B (en) | A kind of preparation method of anti-tumor drug AZD9291 | |
CN104177292A (en) | Method for industrial production of sorafenib tosylate polymorphic form I | |
CN102775344B (en) | Method for preparing 2,3,6-trichloro-trichloromethylpyridine from DCTC (dichlorobenzotrichloride) flash bottoms | |
AR076969A1 (en) | A PROCEDURE FOR THE PREPARATION OF FEBUXOSTAT | |
CN103012194B (en) | Nitrine ester compound and synthesis method thereof | |
CN105175329A (en) | New synthesis route and method of bedaquiline racemate | |
CN105985294A (en) | Preparation method for olaparib | |
CN104844491B (en) | A kind of synthetic method of dithiocarbamate | |
CN104072397A (en) | Synthesis method for aziridine derivative | |
CN102875544B (en) | Preparation technology of solifenacin succinate | |
CN103772278A (en) | Important tetrahydroisoquinoline derivative midbody and synthesis method thereof | |
CN104072357A (en) | Synthetic method for difluoroethanoic acid | |
CN103980229B (en) | A kind of preparation method of N-phenylpiperazine | |
CN104774202A (en) | Synthesis method of 9H-pyridino[2,3-b]indole compounds | |
CN104003943A (en) | Preparation method for ticagrelor intermediate | |
CN104557763B (en) | Method for synthesizing 2-isopropyl-4-(methylaminomethyl)thiazole | |
CN102786466B (en) | Synthetic method of chiral Salan ligand | |
CN105732454A (en) | Production technology of L-pyroglutamic acid benzyl ester | |
CN105503868A (en) | Imidazo heterocycle carbamic acid ester derivate and preparation method and application thereof | |
CN103193720B (en) | Preparation method of pirimicarb | |
CN103086818A (en) | Method for synthesizing alpha-oxyamide with 2-hydroxy propylene cyanide | |
CN104496892A (en) | Novel technology for synthesizing 4-dimethylamino-pyridine | |
CN104496913A (en) | Method for preparing 5-substituted-2,4-dimethylsulfenyl pyrimidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141001 |